Head and neck cancers include the tongue, mouth, and throat.

The Head & Neck Cancer Disease Site Group (Head & Neck Cancer DSG) produces evidence-based reports to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances. Reports produced by this group are available below.

• The Role of Neoadjuvant Chemotherapy in the Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck (Excluding Nasopharynx)
  5-1 PG: February 2003 Update
  
  • Summary
  • Summary & Full Report
• The Management of Head and Neck Cancer in Ontario 
  5-3 PG: May 2009
  
  • Summary
  • Summary & Full Report
• Optimum Radiation Fractionation for T1 NO Glottic (Vocal Cord) Carcinoma
  5-4 ES: March 2005 Update
  
  • Summary
  • Summary & Full Report
• Symptomatic Treatment of Radiation-Induced Xerostomia in Head and Neck Cancer Patients
  5-5 PG: March 2004 Update
  
  • Summary
  • Summary & Full Report
• Hyperfractionated Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
  5-6b PG: January 2003 Update
  
  • Summary
  • Summary & Full Report
• Accelerated Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
  5-6c PG: October 2002
  
  • Summary
  • Summary & Full Report
• Chemotherapy with Radiotherapy for Nasopharyngeal Cancer
  5-7 EBS: December 2004 Update
  
  • Practice Guideline
  • Evidence-Based Series
• The Role of Amifostine as a Radioprotectant in the Management of Patients with Squamous Cell Head and Neck Cancer
  5-8 PG: March 2004 Update
  
  • Summary
  • Summary & Full Report
• The Role of Post-operative Chemoradiotherapy for Squamous Cell Carcinoma of the Head and Neck
  5-10 EBS: December 2004
  
  • Practice Guideline
  • Evidence-Based Series
• Epidermal Growth Factor Receptor (EGFR) Targeted Therapy in Stage III and IV Head and Neck Cancer
  5-12 EBS: May 2009
  
  • Practice Guideline
  • Evidence-Based Series

• Concomitant Chemotherapy and Radiotherapy in Squamous Cell Head and Neck Cancer (Excluding Nasopharynx)
  5-6a PG: March 2000 Update
  

  July 2007: This guideline requires updating and has been removed to be rewritten.
  The original guideline is available upon request at ccopgi@mcmaster.ca .